Across the recent three months, 10 analysts have shared their insights on Marsh & McLennan MMC, expressing a variety of opinions spanning from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
| Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
|---|---|---|---|---|---|
| Total Ratings | 1 | 2 | 5 | 2 | 0 |
| Last 30D | 0 | 0 | 0 | 1 | 0 |
| 1M Ago | 0 | 1 | 1 | 0 | 0 |
| 2M Ago | 0 | 1 | 1 | 0 | 0 |
| 3M Ago | 1 | 0 | 3 | 1 | 0 |
The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $235.8, a high estimate of $259.00, and a low estimate of $212.00. Surpassing the previous average price target of $228.11, the current average has increased by 3.37%.
Exploring Analyst Ratings: An In-Depth Overview
An in-depth analysis of recent analyst actions unveils how financial experts perceive Marsh & McLennan. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
| Analyst | Analyst Firm | Action Taken | Rating | Current Price Target | Prior Price Target |
|---|---|---|---|---|---|
| Meyer Shields | Keefe, Bruyette & Woods | Raises | Underperform | $214.00 | $212.00 |
| Jimmy Bhullar | JP Morgan | Raises | Neutral | $235.00 | $230.00 |
| Scott Heleniak | RBC Capital | Raises | Outperform | $250.00 | $242.00 |
| David Motemaden | Evercore ISI Group | Announces | Outperform | $242.00 | - |
| Alex Scott | Barclays | Raises | Equal-Weight | $246.00 | $236.00 |
| Michael Zaremski | BMO Capital | Raises | Market Perform | $228.00 | $217.00 |
| Brian Meredith | UBS | Raises | Buy | $259.00 | $255.00 |
| Meyer Shields | Keefe, Bruyette & Woods | Raises | Underperform | $212.00 | $209.00 |
| Harry Fong | Roth MKM | Raises | Neutral | $230.00 | $220.00 |
| Scott Heleniak | RBC Capital | Raises | Sector Perform | $242.00 | $232.00 |
Key Insights:
- Action Taken: Analysts adapt their recommendations to changing market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their response to recent developments related to Marsh & McLennan. This information provides a snapshot of how analysts perceive the current state of the company.
- Rating: Analysts assign qualitative assessments to stocks, ranging from 'Outperform' to 'Underperform'. These ratings convey the analysts' expectations for the relative performance of Marsh & McLennan compared to the broader market.
- Price Targets: Analysts predict movements in price targets, offering estimates for Marsh & McLennan's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.
Capture valuable insights into Marsh & McLennan's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
Stay up to date on Marsh & McLennan analyst ratings.
Get to Know Marsh & McLennan Better
Marsh McLennan is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (a management and economic consultancy). About half of its revenue is generated outside the US.
Marsh & McLennan: A Financial Overview
Market Capitalization: Surpassing industry standards, the company's market capitalization asserts its dominance in terms of size, suggesting a robust market position.
Revenue Growth: Marsh & McLennan's revenue growth over a period of 3 months has been noteworthy. As of 30 September, 2024, the company achieved a revenue growth rate of approximately 5.85%. This indicates a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Financials sector.
Net Margin: Marsh & McLennan's net margin excels beyond industry benchmarks, reaching 13.11%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): Marsh & McLennan's financial strength is reflected in its exceptional ROE, which exceeds industry averages. With a remarkable ROE of 5.52%, the company showcases efficient use of equity capital and strong financial health.
Return on Assets (ROA): Marsh & McLennan's ROA stands out, surpassing industry averages. With an impressive ROA of 1.52%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 1.08.
Analyst Ratings: Simplified
Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. Click here to stay ahead of the market.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
|---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
